Lee Scott Golden Insider Profile
4 Followers
Lee Scott Golden, Director at Cadrenal Therapeutics, Inc., holds ― shares in Cadrenal Therapeutics, Inc. (Ticker: CVKD), holds 79.11K shares in PTC Therapeutics (Ticker: PTCT), holds ― shares in MetaVia (Ticker: MTVA).
Lee Scott Golden's Trading History
You May Also Like
Lee Scott Golden insider profile FAQ
What is the percentage of profitable transactions made by Lee Scott Golden?
The percentage of profitable transactions made by Lee Scott Golden is 44%.
What is the average return per transaction made by Lee Scott Golden?
The average return per transaction made by Lee Scott Golden is -24.80%.
What stocks does Lee Scott Golden hold?
Lee Scott Golden holds: CVKD, PTCT, MTVA stocks.
What was Lee Scott Golden's most profitable transaction?
Lee Scott Golden’s most profitable transaction was an Informative Sell of PTCT stock on January 12, 2026. The return on the trade was 18.10%.
What is Lee Scott Golden's role in Cadrenal Therapeutics, Inc.?
Lee Scott Golden's role in Cadrenal Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
